Corcept Therapeutics
CORT
#3544
Rank
ยฃ2.92 B
Marketcap
ยฃ27.73
Share price
-0.37%
Change (1 day)
-33.71%
Change (1 year)

Market capitalization of Corcept Therapeutics (CORT)

Market cap: ยฃ2.92 Billion

As of January 2026 Corcept Therapeutics has a market cap of ยฃ2.92 Billion. This makes Corcept Therapeutics the world's 3544th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corcept Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ2.92 B-54.81%
2025ยฃ6.46 B47.62%
2024ยฃ4.38 B66.7%
2023ยฃ2.62 B45.42%
2022ยฃ1.80 B6.72%
2021ยฃ1.69 B-24.04%
2020ยฃ2.22 B110.94%
2019ยฃ1.05 B-12.7%
2018ยฃ1.21 B-20.61%
2017ยฃ1.52 B133.44%
2016ยฃ0.65 B77.3%
2015ยฃ0.36 B88.58%
2014ยฃ0.19 B0.55%
2013ยฃ0.19 B120.03%
2012ยฃ88.3 M-52.35%
2011ยฃ0.18 B2.37%
2010ยฃ0.18 B68.68%
2009ยฃ0.10 B209.91%
2008ยฃ34.63 M-43.7%
2007ยฃ61.51 M280.69%
2006ยฃ16.15 M-66.28%
2005ยฃ47.92 M-34.98%
2004ยฃ73.71 M

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Corcept Therapeutics was reported to be:

ยฃ2.91 Billion
by Nasdaq info icon info icon
ยฃ2.92 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ375.09 B 12,735.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ84.28 B 2,784.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ202.01 B 6,812.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ719.39 B 24,516.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ106.66 B 3,549.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ202.46 B 6,827.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ0.62 B-78.62%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
ยฃ1.31 B-54.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ8.23 B 181.63%๐Ÿ‡บ๐Ÿ‡ธ USA